Cargando…
Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection
A pandemic brought on by COVID-19 has created a scalable health crisis. The search to help alleviate COVID-19-related complications through therapeutics has become a necessity. Zofin is an investigational, acellular biologic derived from full-term perinatal amniotic fluid that contains extracellular...
Autores principales: | Bellio, Michael A., Bennett, Cassie, Arango, Alissa, Khan, Aisha, Xu, Xiumin, Barrera, Cesar, Friedewald, Vincent, Mitrani, Maria Ines |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611818/ https://www.ncbi.nlm.nih.gov/pubmed/34841370 http://dx.doi.org/10.1016/j.bbiosy.2021.100031 |
Ejemplares similares
-
Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic
por: Mitrani, Maria Ines, et al.
Publicado: (2021) -
Human amniotic fluid derived extracellular vesicles attenuate T cell immune response
por: del Rivero, Tania, et al.
Publicado: (2022) -
Administration of amniotic fluid derived extracellular vesicle is associated with decreased crp in COVID-19 patients
por: Mitrani, M., et al.
Publicado: (2021) -
Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients
por: Mitrani, Maria Ines, et al.
Publicado: (2021) -
Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)